Ultragenyx (RARE) EVP/CLO Karah Parschauer Herdman Sells 1,900 Shares

What Happened

• Karah Parschauer Herdman, Executive Vice President and Chief Legal Officer of Ultragenyx Pharmaceutical Inc. (RARE), disposed of 1,900 shares of company stock in an open-market sale on August 3, 2026. The shares were sold at $24.92 per share for a total proceeds of $47,348.
• This was a sale (S) transaction. Sales by insiders are common and may be routine (e.g., for diversification or liquidity) and do not necessarily signal a change in view about the company.

Key Details

• Transaction date: 2026-08-03; Price: $24.92 per share; Shares sold: 1,900; Total value: $47,348.
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: F1 — the filing notes inclusion of previously reported shares underlying RSUs granted to the reporting person that remain subject to vesting conditions.
• Filing timeliness: Reported on Form 4 filed 2026-08-04 for the 2026-08-03 transaction (filed the next business day), indicating a timely disclosure.

Context

• This was a straight sale of existing shares (no option exercise or award involved). Such dispositions are routine for many insiders and don’t by themselves indicate positive or negative sentiment about Ultragenyx.
• Retail investors typically view purchases as stronger signals than routine sales; use this disclosure as one data point alongside other insider activity and company fundamentals.